Special Issue "Cellular Regeneration Therapy for Traumatic Brain Injury (TBI)"

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".

Deadline for manuscript submissions: 29 December 2023 | Viewed by 104

Special Issue Editor

Dr. Xiang Gao
E-Mail Website
Guest Editor
Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
Interests: neural protection; neural degeneration and regeneration; glia response; neural circuitry modulation; traumatic brain injury

Special Issue Information

Dear Colleagues,

TBI is a major cause of death and disability worldwide, affecting more than 10 million people annually. Due to its complexity, TBI currently remains untreatable. Therefore, tremendous effort has been made to develop effective therapies. This Special Issue aims to demonstrate the new advancements in the development of regenerative therapies at the cellular level for TBI treatment. They include (but are not limited to) using genetically modified cells for axon, dendrite, and synapse regeneration; diminishing or repopulating specific types of cells for function recovery; delivering specific types of cells or cell products for the repair of neural circuits; compensating for lost cells or regenerating lost brain tissues via in vivo iPS reprogramming, and so on.

Dr. Xiang Gao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • traumatic brain injury
  • regenerative therapy
  • neural regeneration
  • genetic modification
  • stem-cell therapy
  • cell transplantation
  • in vivo iPS reprogramming

Published Papers

This special issue is now open for submission.
Back to TopTop